Yang Li, Ph. D

Scientist
Enanta Pharmaceuticals, Inc.

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1123 - EDP-235, A Potent and Once-daily Oral Antiviral, Demonstrates Excellent Penetration into Macrophages and Monocytes, with the Potential for Mitigation of Cytokine Storm in High-Risk COVID-19 Patients
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET